Suzette Kox, MPharm: Pharmacovigilance and Nonproprietary Names for Biosimilars
April 15th 2019Suzette Kox, MPharm, Secretary General of the International Generic and Biosimilar Medicines Association (IGBA), discusses the European experience with using nonproprietary names for biosimilar pharmacovigilance.
Lawrence Shulman, MD: The Global Impact of Biosimilar Trastuzumab
January 7th 2019Lawrence Shulman, MD, deputy director for clinical services and director of the Center for Global Cancer Medicine at the Abramson Cancer Center at the University of Pennsylvania, discusses the global impact of biosimilar trastuzumab.
Lawrence Shulman, MD: Preparing for Biosimilar Trastuzumab
January 2nd 2019Lawrence Shulman, MD, deputy director for clinical services and director of the Center for Global Cancer Medicine at the Abramson Cancer Center at the University of Pennsylvania, discusses the arrival of biosimilar trastuzumab.